The nation’s biotech industry has had a strong performance over the past few years, with turnover for the sector hitting NT$191.2 billion (US$6.34 billion) last year — double the figure for 2000 — a report released by the Council for Economic Planning and Development said yesterday.
The council, which drafts proposals for national economic development and coordinates and evaluates their implementation, said the number of listed and over-the-counter biotech companies had increased ninefold since 2000.
The industry includes biotech companies, pharmaceutical firms and suppliers of other medical supplies and equipment, the report said, adding that annual growth for the sector averaged 11 percent between 2000 and last year.
In 2006, providers of medical supplies and equipment outperformed drug makers in terms of business volume.
Taiwanese companies selling electronic thermometers, digital blood pressure meters, electric wheelchairs and respiratory therapy equipment accounted for more than 30 percent of the global market for those products, the report said.
The rosy business outlook has led to investment in the industry increasing 123 percent over the last seven years, the report said. The spending amounted to NT$12.1 billion in 2000, topped NT$20 billion in 2001 and hit NT$27 billion last year.
The government has said it prioritizes the industry’s growth and last July the Biotech and Pharmaceutical Industry Development Statute (生技新藥產業發展條例) was promulgated.
The statute provides tax breaks and other incentives for companies in the industry that spend on research and development, personnel training and transfer of know-how. The incentives, effective until the end of 2021, will make the biotech and pharmaceutical industry the sole beneficiary of tax breaks once the Statute for Upgrading Industries (促進產業升級條例) expires at the end of next year.
Employees in biotech companies who receive stock options also do not have to pay income tax on the shares under last year’s statute. In addition, government researchers can work as consultants at the companies and transfer their know-how to them.
RUN IT BACK: A succesful first project working with hyperscalers to design chips encouraged MediaTek to start a second project, aiming to hit stride in 2028 MediaTek Inc (聯發科), the world’s biggest smartphone chip supplier, yesterday said it is engaging a second hyperscaler to help design artificial intelligence (AI) accelerators used in data centers following a similar project expected to generate revenue streams soon. The first AI accelerator project is to bring in US$1 billion revenue next year and several billion US dollars more in 2027, MediaTek chief executive officer Rick Tsai (蔡力行) told a virtual investor conference yesterday. The second AI accelerator project is expected to contribute to revenue beginning in 2028, Tsai said. MediaTek yesterday raised its revenue forecast for the global AI accelerator used
TEMPORARY TRUCE: China has made concessions to ease rare earth trade controls, among others, while Washington holds fire on a 100% tariff on all Chinese goods China is effectively suspending implementation of additional export controls on rare earth metals and terminating investigations targeting US companies in the semiconductor supply chain, the White House announced. The White House on Saturday issued a fact sheet outlining some details of the trade pact agreed to earlier in the week by US President Donald Trump and Chinese President Xi Jinping (習近平) that aimed to ease tensions between the world’s two largest economies. Under the deal, China is to issue general licenses valid for exports of rare earths, gallium, germanium, antimony and graphite “for the benefit of US end users and their suppliers
Dutch chipmaker Nexperia BV’s China unit yesterday said that it had established sufficient inventories of finished goods and works-in-progress, and that its supply chain remained secure and stable after its parent halted wafer supplies. The Dutch company suspended supplies of wafers to its Chinese assembly plant a week ago, calling it “a direct consequence of the local management’s recent failure to comply with the agreed contractual payment terms,” Reuters reported on Friday last week. Its China unit called Nexperia’s suspension “unilateral” and “extremely irresponsible,” adding that the Dutch parent’s claim about contractual payment was “misleading and highly deceptive,” according to a statement
Artificial intelligence (AI) giant Nvidia Corp’s most advanced chips would be reserved for US companies and kept out of China and other countries, US President Donald Trump said. During an interview that aired on Sunday on CBS’ 60 Minutes program and in comments to reporters aboard Air Force One, Trump said only US customers should have access to the top-end Blackwell chips offered by Nvidia, the world’s most valuable company by market capitalization. “The most advanced, we will not let anybody have them other than the United States,” he told CBS, echoing remarks made earlier to reporters as he returned to Washington
RSS